A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
Public ClinicalTrials.gov record NCT00002239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Controlled Phase 2 Trial Assessing Three Doses of T-20 in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz in HIV-1 Infected Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see if it is safe and effective to give T-20, a new type of anti-HIV drug, with a combination of other anti-HIV drugs. The other anti-HIV drugs used are abacavir (ABC), amprenavir (APV), ritonavir (RTV), and efavirenz (EFV). Three different doses of T-20 are tested.
Study identification
- NCT ID
- NCT00002239
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 68 participants
Conditions and interventions
Conditions
Interventions
- Enfuvirtide Drug
- Ritonavir Drug
- Abacavir sulfate Drug
- Amprenavir Drug
- Efavirenz Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 1999 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Nov 15, 2005
Started 1999
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Oaks Research | Beverly Hills | California | 90211 | — |
| UCLA Care Ctr | Los Angeles | California | 90095 | — |
| ViRx Inc | Palm Springs | California | 92262 | — |
| Donald Northfelt | Palm Springs | California | 92270 | — |
| UCSD | San Diego | California | 92103 | — |
| ViRx Inc | San Francisco | California | 94109 | — |
| Quest Clinical Research | San Francisco | California | 94115 | — |
| Dupont Circle Physicians Group | Washington D.C. | District of Columbia | 200091104 | — |
| IDC Research Initiative | Altamonte Springs | Florida | 32701 | — |
| Gary Richmond MD | Fort Lauderdale | Florida | 33316 | — |
| AIDS Research Consortium of Atlanta | Atlanta | Georgia | 30308 | — |
| Johns Hopkins Hosp | Baltimore | Maryland | 21287 | — |
| Washington Univ School of Medicine | St Louis | Missouri | 63110 | — |
| New York Univ Med Ctr | New York | New York | 10016 | — |
| Trimeris Inc | Durham | North Carolina | 27707 | — |
| Associates of Med and Mental Health | Tulsa | Oklahoma | 74114 | — |
| Pennsylvania Oncology and Hematology Associates | Philadelphia | Pennsylvania | 19106 | — |
| Philadelphia FIGHT | Philadelphia | Pennsylvania | 19107 | — |
| Univ of Pittsburgh | Pittsburgh | Pennsylvania | 15261 | — |
| Central Texas Clinical Research | Austin | Texas | 78705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 15, 2005 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00002239 live on ClinicalTrials.gov.